Cerebra Integrated Technologies: Q1 loss narrows to ₹6.5 crore

Cerebra Integrated Technologies Limited reported a consolidated net loss of ₹6.46 crore for the quarter ended June 30, 2026, with the loss narrowing about 54% from the corresponding quarter a year earlier. However, sales declined to ₹0.32 crore, down 82.12% year-on-year, underscoring the company’s weak operating scale ahead of its next results announcement.

What did Cerebra report for Q1 FY27?

Cerebra Integrated Technologies Limited, referred to hereafter as Cerebra, approved its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, at its board meeting on August 13, 2026. The results were prepared under Indian Accounting Standards and were accompanied by a limited review report, according to the company’s exchange filing.

The reported consolidated net loss was ₹6.46 crore, equivalent to a loss per share of ₹0.58. The loss per share was lower than the ₹1.26 loss per share reported for the first quarter of the previous financial year. The supplied earnings data describes the net loss as narrowing by about 54% year-on-year.

Sales for the June 2026 quarter stood at ₹0.32 crore. This was substantially lower than ₹1.79 crore in the June 2025 quarter and ₹1.14 crore in the March 2026 quarter. The sequential decline was 71.93%, while the year-on-year fall was 82.12%.

How did Cerebra's operating performance change?

Cerebra recorded an operating loss of ₹5.81 crore in the June 2026 quarter, compared with an operating loss of ₹33 crore in the March 2026 quarter. The smaller operating loss reflected a sharp reduction in reported expenses from ₹34 crore in March to ₹6.13 crore in June.

Expenses nevertheless remained far above quarterly sales. With revenue at ₹0.32 crore and expenses at ₹6.13 crore, the operating profit margin was negative 1,815.63%. This shows that the reduction in losses did not arise from a recovery in revenue during the quarter.

The company’s sales have remained low across recent quarters. Sales were ₹2.21 crore in September 2025, ₹0.82 crore in December 2025, ₹1.14 crore in March 2026 and ₹0.32 crore in June 2026. The quarterly figures indicate an uneven and contracting revenue base over this period.

Why are the June-quarter figures important for investors?

The June-quarter result is important because the reported year-on-year reduction in net loss coincided with a steep fall in sales. For investors, this makes the movement in expenses and the sustainability of operations as relevant as the narrower reported loss.

Cerebra’s expense base declined significantly from the preceding March quarter, which reduced the operating loss in absolute terms. But revenue fell by more than two-thirds sequentially, leaving expenses at more than 19 times sales for the June quarter. The company therefore remained loss-making at the operating level.

The provided market report said Cerebra’s share price softened 4.96% to ₹2.68 after the results cited in the material. The reported price reaction occurred against a backdrop of weak revenue and continued losses, although the supplied information does not establish how long that market movement lasted or identify other trading factors.

When will Cerebra announce its next quarterly results?

Cerebra is scheduled to hold a board meeting on November 12, 2026, to consider and approve unaudited standalone and consolidated results for the second quarter and half year ended September 30, 2026. The company informed BSE of the planned meeting through its board-meeting intimation.

That disclosure identifies the next formal financial update after the June-quarter results. The company’s earlier financial calendar shows quarterly results on August 13, 2026, while audited results for the quarter and year ended March 31, 2026 were announced on May 29, 2026.

The supplied material also refers to a Securities Appellate Tribunal decision dated October 6, 2025, which upheld a modified Securities and Exchange Board of India order allowing a proposed ₹400 crore equity issuance to Dr. Shailesh Hiranandani and SRAM & MRAM Group (UK). The material does not provide an update on the completion, timing or financial effect of that proposed issuance.

Conclusion

Cerebra’s Q1 FY27 loss narrowed to ₹6.46 crore, but the improvement came alongside sales of only ₹0.32 crore and a continued operating loss of ₹5.81 crore. The figures point to materially lower expenses than in the March quarter, while also highlighting the gap between the company’s revenue and operating costs.

Investors will next watch Cerebra’s September-quarter and half-year results, scheduled for board consideration on November 12, 2026. Key disclosed matters to monitor are whether sales recover from the June-quarter level, how expenses change, and whether the company provides any update on the proposed ₹400 crore equity issuance.